Skip to main content

WELLS FARGO & COMPANY/MN

Position in WVE — Wave Life Sciences, Inc.

CIK 72971 SAN FRANCISCO, CA

Position in WVE

as of Jun 30, 2026 · filed Aug 14, 2026
Position Value
$895,965
-$91,288 QoQ
Shares Held
154,211
+13.2% QoQ
Ownership
0.078%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#83
of 237 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in WVE Over Time

Shares Held

Position Value (USD)

Derivatives in WVE

reported options exposure · as of Mar 31, 2021
CallValue
$119,493
CallShares
21,300
PutValue
$119,493
PutShares
21,300

Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.

Position in Biotechnology

Healthcare · as of Jun 30, 2026

WELLS FARGO & COMPANY/MN holds $1,567,775,044 across 417 Biotechnology names. WVE ranks #142 (0.1% of the industry book) .

# Ticker Company Shares Value (USD) Open

All Filings in WVE

Export CSV
28 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $895,965 154,211
2026-03-31 $987,253 136,173
2025-12-31 $3,415,130 200,890
2025-09-30 $540,295 73,811
2025-06-30 $810,335 124,667
2025-03-31 $1,801,532 222,962
2024-12-31 $616,718 49,856
2024-09-30 $221,260 26,983
2024-06-30 $137,568 27,569
2024-03-31 $160,907 26,079
2023-12-31 $92,207 18,259
2023-09-30 $84,295 14,660
2023-06-30 $82,129 22,563
2023-03-31 $1,900 439
2022-12-31 $3,024 432
2022-09-30 $1,519 421
2022-06-30 $1,066 328
2022-03-31 $9,008 4,504
2021-12-31 $63,434 20,202
2021-09-30 $357 73
2021-06-30 $486 73
2021-03-31 $126,937 22,627
2021-03-31 $119,493 21,300
2021-03-31 $119,493 21,300
2020-12-31 $207,893 26,416
2020-09-30 $121,627 14,326
2020-06-30 $178,427 17,140
2020-03-31 $141,674 15,120